Arcus Biosciences
(NYSE) RCUS
Arcus Biosciences Financials at a Glance
Market Cap
$2.78B
Revenue (TTM)
$247.00M
Net Income (TTM)
$353.00M
EPS (TTM)
$-3.30
P/E Ratio
-6.73
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$22.47
Volume
826,465
Open
$21.91
Price
$22.47
Volume
826,465
Open
$21.91
Previous Close
$22.43
Daily Range
$21.71 - $22.86
52-Week Range
$6.50 - $26.40
Dividend
$0.00
Beta (Volatility)
1.55 (High)
Price
$22.47
Volume
826,465
Open
$21.91
Previous Close
$22.43
Daily Range
$21.71 - $22.86
52-Week Range
$6.50 - $26.40
RCUS News
RCUS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arcus Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
601
CEO
Terry J. Rosen, PhD
Website
arcusbio.comHeadquarters
Hayward, CA 94545, US
RCUS Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
-2%
Net Income Margin
-1%
Return on Equity
-63%
Return on Capital
-43%
Return on Assets
-31%
Earnings Yield
-14.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.78B
Shares Outstanding
125.35M
Volume
826.47K
Short Interest
0.00%
Avg. Volume
1.28M
Financials (TTM)
Gross Profit
$237.00M
Operating Income
$386.00M
EBITDA
$335.00M
Operating Cash Flow
$482.00M
Capital Expenditure
$2.00M
Free Cash Flow
$484.00M
Cash & ST Invst.
$981.00M
Total Debt
$99.00M
Arcus Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$33.00M
+26.9%
Gross Profit
$30.00M
+15.4%
Gross Margin
90.91%
N/A
Market Cap
$2.78B
N/A
Market Cap/Employee
$4.44M
N/A
Employees
627
N/A
Net Income
$98.00M
-4.3%
EBITDA
$81.00M
+9.0%
Quarterly Fundamentals
Net Cash
$882.00M
-3.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$99.00M
+106.3%
Short Term Debt
$0.00
-100.0%
Return on Assets
-30.99%
N/A
Return on Invested Capital
-42.51%
N/A
Free Cash Flow
$121.00M
-19.8%
Operating Cash Flow
$120.00M
-20.0%